"10.1371_journal.pmed.1001104","plos medicine","2011-10-11T00:00:00Z","Marlieke E A de Kraker; Peter G Davey; Hajo Grundmann; on behalf of the BURDEN study group","Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; Department of Medical Microbiology, Academic Medical Centre Groningen, Groningen, The Netherlands; Quality, Safety and Informatics Research Group, Dundee, United Kingdom","ICMJE criteria for authorship read and met: MdK PD HG. Agree with the manuscripts results and conclusions: MdK PD HG. Designed the experiments/the study: HG MdK PD. Analyzed the data: MdK. Wrote the first draft of the paper: MdK. Contributed to the writing of the paper: MdK HG PD.","All authors have read the journals policy and HG and MdK have declared that they have no competing interests. PD has the following conflicts, he has received support for research projects about the management of infection from Janssen Cilag and about the epidemiology of asthma from Glaxo Smith Kline. He has been a member of an Advisory Board on antimicrobial resistance for Wyeth and an Advisory Board about new antibiotics for Johnson and Johnson. He has received speaker fees and support to attend meetings from Johnson & Johnson and Optimer Pharmaceuticals.","2011","10","Marlieke E A de Kraker","MEADK",4,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA
